There are 12 resources available
Welcome and Course Overview
Presenter: F. Thistlethwaite, UK, C. Bonini, IT
Session: Welcome and course overview
Resources:
Slides
Webcast
Haematology (CD19 CAR-T)
Presenter: P. Corradini, IT
Session: Session 1 - Where are we now?
Resources:
Slides
Webcast
Solid Tumours (Melanoma TIL, CAR-T, TCR Gene Modified Cells NYESO+New Developments)
Presenter: F. Thistlethwaite, UK
Session: Session 1 - Where are we now?
Resources:
Slides
Webcast
New Targets e.g. BCMA, CD20 (Plus Dual Targeting)
Presenter: H. Einsele, DE
Session: Session 2 - New approaches
Resources:
Slides
Webcast
Genetic Manipulation e.g. Genome Editing, Gene Modified TIL, Armoured CARS
Presenter: C. Bonini, IT
Session: Session 2 - New approaches
Resources:
Slides
Webcast
New Cell Types e.g. NK, Universal CAR-T
Presenter: U. Koehl, DE
Session: Session 2 - New approaches
Resources:
Slides
Webcast
Development Institutional Readiness (e.g. Facilities, Ambulatory Care, Cell Storage/Processing, Educational and Training)
Presenter: C. Chabannon, FR
Session: Session 3 - Optimisig Access to Cell Therapies: Regulatory and Funding Issues - Part 1
Resources:
Slides
Webcast
Health Registries
Presenter: J. Kuball, NL
Session: Session 3 - Optimisig Access to Cell Therapies: Regulatory and Funding Issues - Part 1
Resources:
Slides
Webcast
Health Econominc Models
Presenter: P. Morgese, BE
Session: Session 3 - Optimisig Access to Cell Therapies: Regulatory and Funding Issues - Part 2
Resources:
Slides
Webcast
Workshop 1 - Toxicity Management e.g. CRS, ICANS
Presenter: S. Mastaglio, IT
Session: Session 3 - Optimisig Access to Cell Therapies: Regulatory and Funding Issues - Part 2
Resources:
Slides
Webcast